The Indian biotechnology market grew 17.0% in 2009 to Rs 14,199 crore ($3.05 billion). Biopharmaceutical, BioService, BioAgri, BioIndustrial and Bioinformatics products accounted for 62%, 18%, 14%, 4% and 2% of sales, respectively. The fastest-growing sectors were BioServices and BioAgri, which each grew more than 20%. Exports increased 5.3% to account for 53% of sales, while […]

The Algerian government has approved plans to spend $1.48 billion on scientific research over a five-year period. The first phase of the project consists of 34 programs with a goal of increasing the number of researchers in the country by a third to 28,000. The number of labs is expected to increase to 1,200. Areas […]

According to Cefic, the European Chemical Industry Council, production by the EU chemical industry will increase 9.5% this year, excluding pharmaceuticals. In 2009, EU chemical production declined 11.3%, excluding pharmaceuticals. The recovery this year has been driven by inventory corrections, but uncertainty remains due to the EU’s uncertain economic recovery. Capacity utilization for producers remains […]

According to CMR International’s annual yearbook for 2009, pharmaceutical company spending on R&D declined 0.3%, with R&D as a percentage of sales falling to 15%. Compared to the 2004–2006 period, the number of drugs abandoned during Phase III clinical trials nearly doubled in 2007–2009 to 40. For every 12 drugs in preclinical research, two progressed […]

The US Department of Agriculture (USDA) released a report this month detailing the US’s production and consumption capacities for biofuels. New US Renewable Fuel Standards (RFS2), which take effect July 1, mandate the use of 36 billion gallons of bio-based transportation fuels by 2022. The EPA estimates that 15 billion gallons could come from conventional […]

Demand for DNA testing in US crime labs from 2005 to 2008 increased despite federal funding for the DNA Initiative, which is administered by the National Institute of Justice (NIJ). Demand is increasing due to greater awareness, the use of DNA testing in property crimes, advances in DNA science, the reopening of old cases and […]

US equity markets surged in early June due to lower unemployment claims, strong Chinese exports and subsiding anxieties over the European debt crisis. However, conflicting economic data, including weak home and retail sales, along with a cautious outlook from the Federal Reserve shifted market sentiment. In addition, the first-quarter US GDP growth rate was again […]

Heidelberg, Germany and Lexington, MA 6/23/10—Microfluidics firm febit has announced a restructuring in order to focus on blood-based microRNA biomarker discovery, including collaborations and services for clinical researchers. The company’s workforce will be reduced by 60%. President and CEO Cord F. Staehler has resigned and was replaced by Hartmut Voss, PhD, and Jochen Kohlhaas, who […]

Baltimore, MD 6/30/10—Celsis In Vitro (Celsis IVT) a provider of specialized in vitro products, has filed suit against Invitrogen, a Life Technologies company, in US District Court in the Northern District of Illinois. The complaint alleges that processes and methods performed by Invitrogen’s CellzDirect subsidiary infringe Celsis IVT’s US Patent No. 7,604,929 (Novel Cellular Compositions […]

Washington, DC 6/10/10—The FDA has notified Illumina that its Infinium HumanHap550 array when used as part of deCODE Genetics and 23andMe’s genetic information businesses is considered a device under section 201(h) of the Federal Food, Drug, and Cosmetic Act. In a letter to Illumina, the FDA stated that the array requires premarket approval for clinical […]